Search - tctmd.com

Displaying 781 - 800 of 1585

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Todd Neale

September 25, 2018

News Opinion Off Script TCT 2018

Off Script: Opacity, Transparency, and Magic Buttons in the Cath Lab

Kwan S. Lee

September 24, 2018

Presentation TCT 2018

Sensing Renal Nerve Activity Before, During, and After Denervation: SyMap

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Jie Wang

September 24, 2018

Presentation TCT 2018

Sensing Renal Nerve Activity Before, During, and After Denervation: Autonomix

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Robert S. Schwartz

September 24, 2018

Presentation TCT 2018

Predicting Responders vs Non-Responders How to Solve the Unmet Need?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Justin E. Davies

September 24, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

Presentation TCT 2018

Who are the Ideal Candidates for Renal Denervation?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Andrew Sharp

September 24, 2018

Presentation TCT 2018

Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now?

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Chandan Devireddy

September 24, 2018

Presentation TCT 2018

STEMI Care: Your STEMI Protocol in 2018

Presenter: David A. Cox, Dmitriy N. Feldman, Cindy L. Grines

September 24, 2018

Presentation TCT 2018

Alcohol-Mediated Renal Denervation Current Status and US Pivotal Trial Plans

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh

September 24, 2018

News Conference News TCT 2018

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Yael L. Maxwell

September 24, 2018

Presentation TCT 2018

Defining Cardiogenic Shock for 2018 and the Future: Hemodynamic vs Hemometabolic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Navin K. Kapur

September 24, 2018

Presentation TCT 2018

Results and Update From the Vessix RE-INFORCE Program

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Martin B. Leon

September 24, 2018

Presentation TCT 2018

Results and Update From the Paradise Hypertension Program (OFF-MED and ON-MED Studies)

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, Ajay J. Kirtane

September 24, 2018

News Conference News TCT 2018

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Lucy Hicks

September 24, 2018

Presentation TCT 2018

Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

Presenter: Felix Mahfoud, Krishna J. Rocha-Singh, David E. Kandzari

September 24, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

Presentation TCT 2018

Uncontrolled Hypertension or Non-Compliant Patient? Assessment, Scope of the Problem, and Implications

Presenter: Vasilios Papademetriou, Paul A. Sobotka, C. Venkata S. Ram

September 24, 2018

Advertisement

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Prematurely Halted Pilot Study Snaps Recent Winning Streak for Renal Denervation

Off Script: Opacity, Transparency, and Magic Buttons in the Cath Lab

Sensing Renal Nerve Activity Before, During, and After Denervation: SyMap

Sensing Renal Nerve Activity Before, During, and After Denervation: Autonomix

Predicting Responders vs Non-Responders How to Solve the Unmet Need?

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Who are the Ideal Candidates for Renal Denervation?

Clinical Trials All Look Positive: Is Renal Denervation Ready for Clinical Practice Now?

STEMI Care: Your STEMI Protocol in 2018

Alcohol-Mediated Renal Denervation Current Status and US Pivotal Trial Plans

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Defining Cardiogenic Shock for 2018 and the Future: Hemodynamic vs Hemometabolic Shock

Results and Update From the Vessix RE-INFORCE Program

Results and Update From the Paradise Hypertension Program (OFF-MED and ON-MED Studies)

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Results and Update From the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Uncontrolled Hypertension or Non-Compliant Patient? Assessment, Scope of the Problem, and Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content